exscientia AI firm Exscientia appoints COO and Head of Drug Discovery By www.pharmafile.com Published On :: Fri, 31 Jan 2020 17:01:26 +0000 AI drug discovery firm Exscientia has announced the appointment of Dr David Hallett as its Chief Operating Officer and Head of Drug Discovery. Bringing 20 years of experience to the role, Dr Hallett’s primary remit will see him take responsibility for the company’s entire drug discovery portfolio, as well as managing pharma collaborations, joint ventures and pipeline projects. He will report to Exscientia Founder and CEO Professor Andrew Hopkins. read more Full Article appointment Exscientia Research and Development Medical Communications Sales and Marketing Business Services Manufacturing and Production
exscientia SRI and Exscientia partner on AI-assisted cancer drug discovery By feedproxy.google.com Published On :: 09 May 2020 00:44:42 +0000 Full Article
